Physician

Pediatric Infectious Disease

Dr. Leslie K. Serchuck, MD

Leslie Serchuck works in the field of Pediatric Infectious Disease. She researched medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30/52 in Research/PrimaryCare. Leslie Serchuck is a published doctor and has 20 publications published. The lastest was: 'A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.'

Publications

An Analysis of Select Emerging Executive Skills in Perinatally HIV-1-Infected Children.
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AI...
Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmi...
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection.
Abnormal visual evoked response in melancholia.
Characteristics of HIV infected adolescents in Latin America: results from the NISDI pediatric study.
Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households.
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes ...
Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites ...
Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infecte...
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results.
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents.
Predictors of immunologic long-term nonprogression in HIV-infected children: implications for initiating therapy.
Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission St...
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Soc...

Schools

Boston University School Of Medicine

Doctors Specialties

Pediatrics
Pediatric Infectious Disease

Accepted Insurances

Education

Boston University Medical Center
Boston University School of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Susan E. Coffin, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Andrew P. Steenhoff, MB CHB This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeffrey S. Gerber, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Jeffrey M. Bergelson, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Julia S. Sammons, MD This Doctor is OpenDoctor Recommended.
	Dr. Cassandra Kazl, MD
	Dr. Melissa A. Schmatz, MD This Doctor is OpenDoctor Recommended.
	Dr. Elana M. McDonald, MD
	Dr. Sara K. Shamimi-Noori, MD
	Dr. Jan N. Widerman, DO
	Dr. Kelly A. Dzialo, MD This Doctor is OpenDoctor Recommended.